Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Underwater colonoscopy technique could make polyp removal safer and faster

NCT ID NCT07490574

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new method called underwater endoscopic submucosal dissection (UESD) for removing large colon growths. Instead of using gas to inflate the colon, the doctor fills it with saline (salt water) to improve visibility and make the procedure easier. The trial involved 295 adults across multiple hospitals in Italy. The goal was to see if UESD is as good as the standard gas-assisted method for removing the entire growth in one piece, and whether it reduces complications and procedure time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Underwater endoscopic submucosal dissection (UESD) procedure
What this could lead to
If successful, this could offer a safer, faster, and more effective way to remove precancerous colorectal growths without surgery.
What could go wrong
This is a completed trial comparing two procedures, so results are known. However, the underwater method may not work for all lesion types or locations, and it requires specialized training.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

295 people

The number who actually took part.

Started

Dec 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 19 years or older Colorectal neoplastic lesion referred for endoscopic submucosal dissection Lesion considered amenable to en bloc endoscopic resection by ESD according to expert pre-procedural endoscopic assessment Written informed consent provided Exclusion Criteria: Known or suspected deep invasive neoplasia Inflammatory bowel disease Uninterrupted antithrombotic therapy Known coagulopathy Any clinical or lesion-related condition considered unsuitable for colorectal ESD by the treating endoscopist

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal neoplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Campus Bio Medico Hospital

    Rome, RM, 00100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.